A Nasal Epithelial Receptor for Staphylococcus aureus WTA Governs Adhesion to Epithelial Cells and Modulates Nasal Colonization by Baur, Stefanie et al.
A Nasal Epithelial Receptor for Staphylococcus aureus
WTA Governs Adhesion to Epithelial Cells and Modulates
Nasal Colonization
Stefanie Baur1., Maren Rautenberg1., Manuela Faulstich2, Timo Grau1, Yannik Severin1,
Clemens Unger3, Wolfgang H. Hoffmann3, Thomas Rudel2, Ingo B. Autenrieth1,4,
Christopher Weidenmaier1,4*
1 Interfacultary Institute for Microbiology and Infection Medicine Tu¨bingen, Department of Medical Microbiology and Hygiene, University of Tu¨bingen, Tu¨bingen,
Germany, 2 Lehrstuhl fu¨r Mikrobiologie, Biozentrum der Universita¨t Wu¨rzburg, Wu¨rzburg, Germany, 3 Institute for Tropical Medicine, University of Tu¨bingen, Tu¨bingen,
Germany, 4German Center for Infection Research (DZIF), Partner Site Tu¨bingen, Tu¨bingen, Germany
Abstract
Nasal colonization is a major risk factor for S. aureus infections. The mechanisms responsible for colonization are still not well
understood and involve several factors on the host and the bacterial side. One key factor is the cell wall teichoic acid (WTA)
of S. aureus, which governs direct interactions with nasal epithelial surfaces. We report here the first receptor for the cell wall
glycopolymer WTA on nasal epithelial cells. In several assay systems this type F-scavenger receptor, termed SREC-I, bound
WTA in a charge dependent manner and mediated adhesion to nasal epithelial cells in vitro. The impact of WTA and SREC-I
interaction on epithelial adhesion was especially pronounced under shear stress, which resembles the conditions found in
the nasal cavity. Most importantly, we demonstrate here a key role of the WTA-receptor interaction in a cotton rat model of
nasal colonization. When we inhibited WTA mediated adhesion with a SREC-I antibody, nasal colonization in the animal
model was strongly reduced at the early onset of colonization. More importantly, colonization stayed low over an extended
period of 6 days. Therefore we propose targeting of this glycopolymer-receptor interaction as a novel strategy to prevent or
control S. aureus nasal colonization.
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Introduction
The nasal cavity is the major reservoir of Staphylococcus aureus,
which asymptomatically colonizes the anterior nares of 20% of the
normal human population persistently [1,2]. The reasons for the
underlying predisposition and the tropism for the human nose are
still unclear. If carriers are infected with S. aureus, the strain found
in the nose is usually also responsible for the infection [1,2]. Since
S. aureus is able to cause a variety of severe diseases, the carrier
status is an important risk factor in both the community and the
healthcare system [1,3].
Despite the importance of nasal colonization, its molecular basis
has still remained largely elusive. Some studies showed that S.
aureus colonizes mostly the anterior parts of the nares and interacts
very efficiently with squamous, keratinized cells [4]. However,
there is clear evidence that S. aureus also interacts with living
ciliated cells in deeper areas of the nasal cavity or even the throat
[5,6,7,8] and might be equally abundant in all parts of the nasal
cavity [9,10]. In addition, S. aureus is even able to persist
intracellularly in nasal epithelial cells of patients suffering from
recurrent sinusitis [5].
S. aureus nasal colonization is a multifactorial process [11] and
host factors [12], as well as S. aureus factors like the polysaccharide
capsule [13], an array of surface protein adhesins [4,14,15,16,17],
and cell wall teichoic acids (WTA) [6,18,19] have been implicated
in nasal colonization. One of the important surface protein
adhesins with a role is nasal colonization is the cell wall anchored
clumping factor B (ClfB). It binds to cytokeratin and keratinized
nasal cells [4] and the squamous cell envelope protein loricrin. The
impact of this molecular interaction on nasal colonization, has
been demonstrated in a mouse model [20].
In a ‘‘state of the art’’ cotton rat model of nasal colonization,
protein adhesins of S. aureus mainly impact the late stages of nasal
colonization whereas the non-protein adhesin WTA played a key
role in the initial stages [6]. This is in line with the fact that
expression of WTA biosynthesis genes is high during early and
later stages of experimental colonization, whereas expression of
protein adhesins like ClfB is low in the early stages but high in the
late stages of colonization [21,22]. WTA is a surface-exposed
polyanionic cell wall glycopolymer (CWG) composed of about 40
ribitolphosphate repeating units which are modified with D-
alanine and N-acetylglucosamine and covalently linked to the
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peptidoglycan [23,24] (Figure S1). Several lines of evidence
indicate a direct interaction of WTA with receptors on nasal
epithelial cells [6,18]. In vivo, WTA is a key factor of nasal
colonization since a WTA-deficient S. aureus mutant was severely
abrogated in colonizing cotton rat noses [18]. Therefore, it is of
great importance to understand the molecular basis of WTA-
mediated adhesion to the epithelial lining of the inner nasal cavity.
We introduce here SREC-I as a receptor for WTA on nasal
epithelial cells. SREC-I, a type F scavenger receptor with six
extracellular EGF-like domains, has first been detected on
endothelial cells, where the receptor is responsible for the uptake
of calreticulin [25] and acetylated low density lipoproteins [26].
Recently, expression of SREC-I was also described in several
epithelial cell lines, such as END1, HELA, and Chang [27]
epithelial cells. In addition expression, albeit at low levels, was also
detected in primary human bronchial epithelial cells (HBEC) [28].
We present here the first evidence for a key role of SREC-I in the
early phases of S. aureus colonization and thus a novel target for
decolonization strategies that can possibly help to protect
individuals from S. aureus infections.
Results
SREC-I is expressed on nasal epithelial cells
In differential pull down experiments of solubilized membrane
proteins from epithelial cells with cell wall preparations from wild-
type S. aureus, a mutant without WTA (tagO) and a mutant with
structurally altered (negatively charged) WTA (dltA), SREC-I was
found as a potential WTA binding partner (data not shown). To
confirm SREC-I expression in primary nasal epithelia of human
and cotton rat origin we isolated cotton rat primary epithelial cells
(CRNECs) (Figure S2A) and used primary human nasal epithelial
cells (HNECs) (Promocell). We evaluated the presence of SREC-I
by reverse transcriptase PCR (RT-PCR), FACS analysis and
confocal microscopy in these cells.
For detection of SREC-I by FACS analysis we used an anti-
human SREC-I antibody and appropriate isotype controls. Both
HNECs and CRNECs stained positive for the receptor with this
antibody (Figure S2B and Figure 1). RT-PCR Primers were
designed based on the mouse and human genome sequence for
SREC-I. For both cell types SREC-I mRNA expression could be
detected (Figure S2C). Confocal microscopy, employing the same
primary antibodies used in the FACS analysis, revealed a weak but
specific signal for SREC-I on HNECs and CRNECs (Figure S3).
We therefore conclude that SREC-I shows considerable surface
exposition on both CRNECs and HNECs.
SREC-I directly interacts with WTA
To demonstrate a direct molecular interaction of SREC-I and
WTA we employed several experimental setups. Due to the
Figure 1. SREC-I on nasal epithelila cells. Surface exposure of SREC-I on HNECs and CRNECs was monitored by FACS with the same anti-human
SREC-I antibody and isotype control. Statistical evaluation on HNECs (A) and on CRNECs (B). Data represent means 6 SD of 3 or 4 independent




About 20% of the human population is colonized by
Staphylococcus aureus. The reservoir of S. aureus is mainly
the human nose. Usually, colonization does not lead to
infection and is therefore without symptoms. However,
when hospitalized patients exhibit a suppressed immune
system, they are at risk of getting infected by their own
nasal S. aureus strain. Therefore, it is important to
understand the events and mechanisms underlying colo-
nization. Until now S. aureus nasal colonization is only
partially understood. One bacterial key factor is a sugar
polymer of S. aureus, termed cell wall teichoic acid (WTA),
which is involved in S. aureus adhesion to cellular surfaces
in the inner part of the nasal cavity. We show here that a
receptor-protein, which is expressed on such cells, binds
WTA and is thereby involved in adhesion of S. aureus to
nasal cells. This mechanism has a strong impact on nasal
colonization in an animal model that resembles the
situation in the human nose. Most importantly, inhibition
of WTA mediated adhesion strongly reduces nasal coloni-
zation in the animal model. Therefore we propose that
targeting of this glycopolymer-receptor interaction could
serve as a novel strategy to control S. aureus nasal
colonization.
WTA Receptor Governs S. aureus Nasal Colonization
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chemical nature of WTA (loss of D-alanine esters during covalent
coupling) it was not possible to use a surface plasmon resonance
(SPR) based approach on the Biacore platform (data not shown).
Therefore, we first studied SREC-I-WTA interaction in a
microtiterplate based binding assay. A biotin-labeled soluble
human SREC-I Fc-chimera, containing the entire extracellular
domains of SREC-I, bound in a dose-dependent and saturable
manner to immobilized WTA (Figure 2A). Using a function-
blocking SREC-I antibody we were able to block interaction of
WTA with SREC-I in a dose-dependent manner (Figure 2B). In
addition, we detected a dose dependent interaction of SREC-I
with WTA in a ligand blot assay (Figure 2C and Figure S4). In this
assay system binding of an SREC-I Fc-chimera to immobilized
WTA is detected with the help of an infrared dye-labeled anti-Fc
antibody. The SREC-I Fc-chimera bound wild-type (wt) WTA
significantly better than negatively charged WTA isolated from a
dltA mutant. Furthermore, we directly labeled the SREC-I Fc-
chimera with FITC and measured binding of the conjugate to
whole bacterial cells in suspension (Figure 2D). We found that
wild-type S. aureus (wt) bound 41%612 of the SREC-I in solution
whereas a mutant lacking all WTA (tagO) bound only 19%68. The
complemented tagO mutant bound 51%615. When we added
MgCl2 in different concentrations, we could partially decrease the
interaction of wild-type S. aureus with the FITC labeled SREC-I
Fc-chimera to the level of the tagO mutant which lacks all WTA.
The diminished interaction of the dltA mutant, which exhibits
negatively charged WTA, was partially restored to wild-type levels
at high MgCl2 concentrations. In addition we could decrease the
interaction of wild-type S. aureus to the FITC labeled SREC-I Fc-
chimera with WTA purified from wild-type S. aureus but not with
WTA purified from the dltA mutant (Figure S5A). To test the
specificity of WTA/SREC-I interaction we used another FITC
labeled scavenger receptor in this assay system. The CD36 FITC
conjugate showed considerable binding to wild-type S. aureus,
however we could not detect a considerable decrease in binding of
the CD36 FITC conjugate to the tagO and dltA mutants as we
could detect with the FITC labelled SREC-I Fc-chimera (Figure
S5B).
SREC-I mediates WTA-dependent adhesion to nasal
epithelial cells
To study the role of WTA-SREC-I interaction in adhesion to
epithelial cells, we performed microscopical assays with fluores-
cently labeled bacteria. We chose the S. aureus strain background
Sa113 for most in vitro and in vivo assays because it colonized the
nasal cavity of cotton rats (see below) significantly better than more
virulent strains like e.g. USA300 or USA400 which also altered the
integrity of epithelial monolayers in adhesion assays under static
conditions (data not shown). WTA exerted an important role in
the adhesion to HNECs as well as CRNECs, since especially
under shear stress conditions a mutant lacking WTA (tagO)
exhibited a strong defect in adhesion (Figure 3). This phenotype
could be complemented by a wild-type copy of the tagO gene on a
plasmid. With HNECs (Figure 3A) we detected a 54% reduced
adhesion of tagO bacteria under static conditions when compared
to wild-type bacteria at an MOI of 10. This phenotype could also
be complemented. Under shear stress conditions the adhesion of
the tagO mutant was reduced by 77%. Complementation of the
tagO mutant nearly restored wild-type levels. With CRNECs we
detected a 55% reduction of the tagO mutant adhesion when
compared to wild-type S. aureus under static conditions (Figure 3B
and Figure S6). Again, this reduction could be complemented by
expressing a wild-type copy of the tagO gene in the tagO mutant.
Under shear stress conditions adhesion of the tagO mutant was
reduced by 67% when compared to the wild-type bacteria.
Complementation of the tagO mutant did nearly restore wild type
levels of adhesion (Figure 3B). With HNECs the adhesion of whole
S. aureus bacterial cells could be partially blocked under static
(Figure 4A) and shear stress condition (Figure 4B) using Fab2-
fragments of a function blocking SREC-I antibody. Fab2-
fragments of an isotype control had no impact on the adhesion
of whole bacteria to HNECs. Under static conditions (Figure 4A),
preincubation with the SREC-I Fab2-fragments decreased the
adhesion of the wild-type by 67%. In contrast, incubation with the
isotype control did not change the level of adhesion. The reduced
level of tagO mutant adhesion was not further influenced by
SREC-I antibody or isotype control preincubation. Under shear
stress conditions (Figure 4B) preincubation with the SREC-I
Fab2-fragments decreased adhesion of the wild-type to HNECs by
81%. Incubation with the isotype control did not significantly
change the level of adhesion when compared to the tests without
Fab2-fragments. The level of tagO mutant adhesion was not
influenced by SREC-I antibody or isotype control preincubation.
The SREC-I Fab2-fragment inhibited adhesion of whole S. aureus
bacteria on CRNECs in a similar manner and adhesion decreased
by 54% (Fig. 4c). Furthermore, the adhesion of additional S. aureus
strains (Newman, SH1000, USA100, USA300 and USA400) could
be blocked with the SREC-I FAb2-fragments, but not with isotype
control Fab2-fragments (Fig. 4D).
Specific, WTA-mediated, adhesion to epithelial cells was
demonstrated with WTA-coated fluorescent beads. Wild-type
WTA-coated beads bound in a dose-dependent manner to
HNECs as demonstrated before [18] and CRNECs (Fig. 5C)
while beads coated with structurally altered dltA WTA (negatively
charged) showed no specific adhesion to HNECs (Fig. 5A and
[18]) and CRNECs (Fig. 5C). In line with bacterial adhesion
assays, the function blocking SREC-I antibody revealed the
impact of this receptor on WTA-dependent adhesion also in assays
employing WTA-coated, fluorescently labeled latex beads
(Figure 5A and B). The antibody blocked adhesion of WTA-
coated beads to HNECs significantly while an isotype control had
no impact on adhesion. In more detail, adhesion of wild-type
WTA-coated beads to HNECs (Figure 5A), was reduced by 72%
after SREC-I antibody preincubation while the isotype control
had no influence on adhesion. Beads incubated with structurally
altered dltA WTA lacking D-alanine side chain esters exhibited a
decrease in adhesion by 78%. The SREC-I antibody and isotype
control did not significantly influence adhesion of dltA WTA-
coated beads. Control beads without WTA exhibited only a weak
binding of 7.2% when compared to wild-type WTA-coated beads.
With CRNECs the same SREC-I antibody blocked adhesion of
WTA-coated beads in a similar manner (Figure 5B). Preincubation
with the SREC-I antibody decreased adhesion by 67%. The
isotype control had no significant impact on adhesion of WTA-
coated beads to CRNECs (Figure 5B).
Experiments with CHO epithelial cells expressing or not
expressing functional SREC-I clearly underscore the role of
WTA-SREC-I interaction in S. aureus adhesion to epithelial cells
(Figure 6). Under flow conditions presence of SREC-I led to a
strong increase in adhesion of wild-type S. aureus whereas no
difference in the significantly lower adhesion of WTA-deficient S.
aureus (tagO mutant) could be detected, irrespective of whether
SREC-I was present or not (Figure 6A). Expression of full length
SREC-I in CHO cells led to a statistically significant 2.3 fold
increase in adhesion of wild-type bacteria. With SREC-I
expressing CHO cells the tagO mutant exhibited a severely
decreased adhesion (72% reduction) when compared to the wild-
type. This residual adhesion was increased by a factor of 1.7 when
WTA Receptor Governs S. aureus Nasal Colonization
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SREC-I was expressed in the CHO cells although this increase
wasn’t statistically significant. The complemented mutant exhib-
ited an adhesion profile that resembled the wild-type.
To localize the region of the SREC-I receptor-mediating
interaction with WTA we used CHO cells expressing SREC-I
with truncated EGF-like domains (Figure 6B). We assayed the
adhesion of S. aureus wild-type, WTA-lacking tagO mutant and the
complemented mutant under static condition. On CHO cells that
express no SREC-I we detected 42621, 37617 and 42624
bacteria/0.1 mm2 CHO cells for wild-type, tagO mutant and
complemented mutant, respectively. Adhesion to CHO cells
expressing SREC-I lacking the EGF domains until domain 4
was not altered when compared to full length SREC-I expressing
cells. However, in CHO cells expressing a truncated SREC-I
lacking the first 4 EGF-like domains we detected a significant drop
in adhesion levels of 61% and 63% for wild-type and comple-
mented mutant strain. The residual adhesion of the tagO mutant
was not affected. These experiments, with CHO cells expressing
successive truncations of SREC-I EGF-domains, led to the
conclusion that the WTA interaction interface of SREC-I and
WTA is located in the EGF domains 3 and 4 or between these
domains (Figure 6B). This is in line with the presence of a stretch
of charged amino acids (Figure S7) that could spatially alternate on
both sides of a possible binding groove for WTA and therefore
potentially represents the interaction surface of SREC-I and
WTA. Interestingly preincubation of wild-type S. aureus with
MgCl2 led to a decrease in adhesion to CRNECs which again
argues for an impact of the WTA charge on SREC-I interaction
(Figure S8A).
SREC-I plays a key role in an in vivo model of nasal
colonization
In order to demonstrate a possible impact of the WTA-SREC-I
interaction on nasal colonization, we employed a cotton rat in vivo
model. The cotton rat model of nasal colonization is a preferred,
well established model for S. aureus since the nasal cavity of cotton
rats shares histological properties with the human nasal cavity and
permits long-term colonization experiments [29]. Most impor-
tantly, cotton rats, as opposed to mice, are susceptible to many
human respiratory pathogens, and experimental diseases develop
similar to those observed in humans [30]. We tested the impact of
a function-blocking antibody and a corresponding isotype control
Figure 2. Direct interaction of SREC-I and WTA. Binding of SREC-I to WTA in a microtiter plate-based assay with immobilized WTA at different
concentrations. Interaction of a biotin-labeled SREC-I Fc-chimera with WTA was detected with a Streptavidin-HRP conjugate. The data represent
means6 SD of 3 independent experiments. (A). Incubation with increasing concentrations of an SREC-I function blocking antibody at a concentration
of 80 mg/ml immobilized WTA. The data represent means 6 SD of 3 independent experiments. (B).Interaction of WTA spotted in increasing
concentrations on a nitrocellulose membrane with a SREC-I Fc-chimera (500 ng/ml)(C). Bound SREC-I Fc-chimera was detected with a secondary
antibody coupled to an 800 nm emitting infrared dye on a LI-COR Odyssey infrared imaging system. A representative experiment is shown here (C).
Binding of SREC-I to whole bacterial cells, measured with a FITC-labeled SREC-I Fc-chimera. Wild-type S. aureus, the isogenic tagO mutant and the
complemented mutant (tagO-pRBtagO) were incubated with 50 mg/ml FITC-labeled SREC-I. The bound fluorescence was calculated by subtracting
the unbound fluorescence from the total fluorescence of the FITC-labeled SREC-I solution. The mean and SD of 3 independent experiments are
shown. Statistical analysis was performed by Student’s t-test. Significant differences vs. wild-type strains are indicated by one (P,0.05), two (P,0.01),
or three (P,0.001) asterisks (*) (D).
doi:10.1371/journal.ppat.1004089.g002
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in the early phases and late phases of nasal colonization
(Figure 6C). At early time points (8 h) upon exposure to S. aureus
the impact of adhesion factors that modulate primary adhesion
should be obvious. We could detect a significant decrease in
colonization after preincubation with Fab2-fragments of the
SREC-I antibody but not with an isotype control. The decrease
in S. aureus CFU after preincubation with the function-blocking
antibody was comparable with the decrease in colonization
observed before with a WTA-deficient tagO mutant [6,18]. After
6 days, colonization in SREC-I antibody treated animals did not
recover to the level observed in non treated animals or isotype
control treated animals. The same effect could be observed in a
different strain background. USA100 colonization of the cotton rat
nares was significantly abrogated after pretreatment with Fab2
fragments of the SREC-I antibody (Figure S8B).
Discussion
An integral step in the establishment and persistence of nasal
colonization is the adhesion of bacteria to nasal epithelial cells and
surface components of epithelial surfaces. Histological evidence led
to the conclusion that S. aureus seems to predominantly colonize
the anterior part of the nasal cavity (vestibulum nasi), which is
lined by a stratified, keratinized, non-ciliated squamous epithelium
[31,32]. The upper cell layers in the anterior part comprise mostly
anucleated, squamous cells termed corneocytes, which are highly
keratinized and are surrounded by a proteinaceous structure
containing loricrin and involucrin [33,34]. However, these cellular
layers are constantly shed, which should contribute to the clearing
of attached bacteria. Therefore, interaction with the epithelial
surface in the anterior part of the nasal cavity cannot fully explain
persistent colonization. This idea is backed by newer evidence that
demonstrates S. aureus interaction with living ciliated cells in deeper
areas of the nasal cavity or even the throat [5,6,7,8]. In addition
bacterial numbers seem to be similar in all parts of the nasal cavity
[9,10]. In this line of thought, we investigated the molecular details
of S. aureus adhesion to cells of the inner nasal cavity. Thus, we
concentrated on primary growing cells isolated from the nasal
cavity of humans and cotton rats. We detected expression of
SREC-I, which is a member of the type F scavenger receptor
family [25], in these cells. Our study is the first report of SREC-I
expression in nasal epithelial cells. SREC-I exhibits six extracel-
lular EGF-like domains, binds acetylated lipoproteins as a natural
substrate [26], and has been identified as an important co-receptor
for Neisseria gonorrhoeae adhesion to epithelial cells [27]. Our
experiments revealed an impact of this receptor on S. aureus
adhesion to nasal epithelial cells in vitro and S. aureus colonization in
a cotton rat model of nasal colonization in vivo.
S. aureus nasal colonization is a multifactorial process and surface
proteins of S. aureus, such as ClfB, show a considerable impact in
animal models of nasal colonization [4,14,35,36,37]. In the cotton
rat model of colonization these proteins seem to be more
important for long-term colonization, whereas WTA impacts on
the early stages while colonization is established [6]. This is in line
with ex vivo analysis of the transcriptional level of WTA
biosynthesis genes (tagO and tarK) and surface protein expressing
genes [21,22] which reveals a late stage upregulation of surface
protein expressing genes.
Interestingly, WTA shows no influence on S. aureus interaction
with keratinized cells in the anterior region of the nasal cavity but
clearly governs part of the adhesion to growing epithelial cells
isolated from deeper parts of the nasal cavity [6,16].
We could show here that WTA specifically binds to SREC-I
and that this facilitates adhesion of S. aureus to growing epithelial
cells of the inner nasal cavity. In binding assays with immobilized
WTA a functional SREC-I Fc-chimera, containing the extracel-
lular domains of SREC-I fused to Fc-fragements, bound WTA in a
dose dependent manner. This binding could be blocked by a
Figure 3. WTA-mediated adhesion of S. aureus to HNECs and CRNECs. S. aureus adherence to confluent human nasal epithelial cells (HNECs)
monitored under static and mild shear stress condition (0.5 dynes) in 24 well plates or flow chamber assays, respectively. Attachment of the S. aureus
wild-type (wt), tagO, and a complemented tagO mutant (tagO compl.) evaluated microscopically by counting at least 6 visible fields per well or
chamber slide containing HNECs (A) or CRNECs (B). The data is expressed as means and SEM of 5 independent experiments (static) or of 6
independent experiments (flow). Statistical analysis was performed by one-way ANOVA with Bonferroni’s multiple comparison test. Significant
differences between groups are indicated by one (P,0.05), two (P,0.01), or three (P,0.001) asterisks (*).
doi:10.1371/journal.ppat.1004089.g003
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SREC-I antibody. In adhesion assays with whole bacteria, S. aureus
mutants that lacked WTA showed a significant defect, and the
adhesion of wild-type S. aureus could be blocked with anti-SREC-I
Fab2-fragments. The effect was especially pronounced under mild
shear stress conditions. These conditions can be found in the nasal
cavity where mucus movement, due to cillial activity and
airstream, constantly creates shear stress conditions at the interface
of bacteria and epithelial surfaces.
To understand the molecular details of SREC-I-WTA interac-
tion we expressed truncated versions of SREC-I in CHO cells.
Adhesion studies with these cells revealed a WTA binding
interface on EGF-domains 3 and 4 of SREC-I. Wild-type WTA
usually exhibits both positively and negatively charged residues in
the ribitol-phosphate repeating units. Interestingly, experiments
with negatively charged, dltA mutant derived WTA that lacks all
D-alanine esters, indicate a role of the D-alanine modification in
WTA/SREC-I interaction. Since we could only partially restore
WTA-SREC-I interaction with the addition of Mg2+, WTA
charge is important but can not be the only determinant of binding
affinity. In line with this notion, inhibition experiments with
purified WTA from wild-type and dltA mutant again demonstrate
the role of the presence of D-alanine esters in the WTA structure.
We therefore postulate that both the zwitterionic charge of the
repeating units and the actual spacing of the charges are required
for SREC-I binding. Charged amino acid residues in the WTA
binding interface of SREC-I are most likely responsible for this
Figure 4. Impact of SREC-I on adhesion of S. aureus to HNECs. Inhibition of SREC-I dependent adhesion to HNECS by Fab2- fragments of an
anti-human SREC-I antibody in 24 well microtiter plate assays under static conditions (A) and shear stress conditions in ibidi chamber slide assays (B).
10 mg/ml of the anti-SREC-I Fab2-fragments and isotype control were used in all assays. Attachment of the S. aureus wild-type (wt), and tagO mutant
was evaluated microscopically by counting at least 6 visible fields per well or chamber slide containing HNECs. The data is expressed as the means
and SEM of 5 independent experiments under static and flow conditions. Statistical analysis was performed by one-way ANOVA with Bonferroni’s
multiple comparison test (A and B). Fab2- fragments of an anti-human SREC-I antibody were also used to test the influence of SREC-I on bacterial
adhesion under flow condition to CRNECs in ibidi chamber slide assays (C). 10 mg/ml of the SREC-I Fab2-fragments and isotype control were used in
all assays. Attachment of the S. aureus wild-type (wt), and tagO mutant was evaluated microscopically by counting at least 6 visible fields per chamber
slide containing CRNECs. The data represent mean and SEM of 5 independent experiments. Statistical analysis was performed by one-way ANOVA
with Bonferroni’s multiple comparison test. (C) We also tested the influence of SREC-I on the adhesion of other S. aureus strain backgrounds (D). Fab2-
fragments of an anti-human SREC-I antibody were used under flow conditions in ibidi chamber slide assays with HNECS. 10 mg/ml of the SREC-I Fab2-
fragments and isotype control were used in all assays. Attachment of the S. aureus Newman (wt), and SH1000 mutant was evaluated microscopically
by counting at least 6 visible fields per chamber slide containing CRNECs. The data represent mean and SEM of 4 independent experiments. Statistical
analysis was performed by one-way ANOVA with Bonferroni’s multiple comparison test. (D) Significant differences between groups are indicated by
one (P,0.05), two (P,0.01), or three (P,0.001) asterisks (*).
doi:10.1371/journal.ppat.1004089.g004
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interaction. Mutational studies of SREC-I are part of the ongoing
research in our laboratory and will reveal the structural
requirements for the WTA-SREC-I interaction.
WTA is one of the most abundant molecules in the
staphylococcal cell wall and therefore might facilitate multiple
interactions of lower affinity which could create kinetically more
favourable conditions for S. aureus binding proteins. Thus, we
postulate that WTA modulates the strength of an initial interaction
between bacterium and an epithelial surface, thereby facilitating
binding protein activity.
In the cotton rat model the function blocking anti-SREC-I
antibody had a significant impact on the initial colonization of the
nasal cavity with S. aureus wild-type bacteria. Therefore, it is
tempting to conclude that in the early stages of colonization, the
initial interaction of S. aureus with nasal surfaces partially takes place
at other sides than the very anterior part of the nasal cavity. In
addition, during later stages and persistent colonization, the inner
part of the nasal cavity likely represents one of several habitates in
the nose [9]. Keeping in mind that cells of the very anterior
epithelial linings are shed and permanently removed from the nasal
cavity, bacteria that enter deeper zones of the nasal cavity might
have better chances to overcome physiological barriers, proliferate
and then disseminate again into other areas of the nasal cavity,
including the anterior (Figure 7). In line with this idea, histological
evidence and in vitro studies suggest that S. aureus can also bind to
nasal epithelial cells deeper inside the nasal cavity [6,38] and is also
taken up by and able to persist within these cells in vivo [5].
Taken together we identified SREC-I as a receptor for WTA on
nasal epithelial cells of human and cotton rat origin. SREC-I binds
WTA most likely through charge interactions. This WTA-SREC-I
interaction plays a key role in the initial stages of nasal
colonization in a cotton rat model. This first report of a bacterial
surface polymer-type-F scavenger receptor interaction could spark
a new interest in charged bacterial surface polymers and their
impact on bacterial interaction with the host. In the particular case
of S. aureus it is worthwhile to speculate that the WTA-SREC-I
interaction might be an interesting target for substances, like the
antibody we used in this study, which could be used to combat S.
Figure 5. Impact of SREC-I on WTA-mediated adhesion to HNECs and CRNECs. The anti-human SREC-I antibody was used to test the
influence of SREC-I on adhesion of WTA-coated latex beads under static condition in a 24 well microtiter plate assays on HNECs (A) and CRNECs (B). A
ratio of 20 beads per epithelial cells was used in all depicted assays. 10 mg/ml of the anti-SREC-I antibody and isotype control were used to test the
impact of SREC-I. Adhesion of the beads coated with wt WTA (HNECs and CRNECs) and dltA WTA (HNECs only) or control beads containing no WTA
(HNECs and CRNECs) was measured in a fluoreader and expressed as relative fluorescence. The data are expressed as the means and SEM of 6
independent experiments. Statistical analysis was performed by one-way ANOVA with Bonferroni’s multiple comparison test (A and B). The dose
dependency of WTA-coated latex beads was tested in assays with CRNECs (C). Adhesion of the beads coated with wt WTA and dltA WTA or control
beads containing no WTA was measured in a fluoreader and expressed as relative fluorescence. The data are expressed as the means and SEM of 5
independent experiments (C). Significant differences between groups are indicated by one (P,0.05), two (P,0.01), or three (P,0.001) asterisks (*).
doi:10.1371/journal.ppat.1004089.g005
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aureus nasal colonization. At least it should be possible to use such
substances as topical treatments, to prevent re-colonization after
eradication of S. aureus in risk patients that require extended
hospitalization. Such an approach could be also used in
combination with vaccination therapy that targets other factors
involved in S. aureus nasal colonization [37]. This could
significantly reduce invasive S. aureus infections during hospital-
ization. In addition, further studies are now required to
understand the impact of SREC-I on nasal colonization from an
epidemiological perspective. We are currently trying to identify
putative functional polymorphisms in SREC-I and correlate these
with nasal carrier status. However, since nasal colonization is a
multifactorial process, polymorphisms in SREC-I will be only one
possible genetic determinant that has to be investigated in
conjunction with other modulators of nasal colonization.
Materials and Methods
Bacterial strains
S. aureus SA113 (ATCC 35556) is a frequently used laboratory
strain [39]. The mutant DtagO [18] was generated in this strain
background by replacing the tagO gene with an erythromycin
resistance cassette. This mutant is devoid of WTA [18]. Plasmid
pRBtagO contains a wild-type copy of tagO and its promoter, and
reconstitutes wild-type level WTA biosynthesis along with all
relevant phenotypic properties [18]. An isogenic S. aureus DdltA
mutant [40] was used as a control in the affinity blotting
experiments. Strains Newman (NCTC 8178) [41] and SH1000
[42] are frequently used laboratory strains. We also included
strains USA100 [43], USA300 [44] and USA400 [44] in selected
experiments.
Figure 6. Impact of SREC-I on adhesion of S. aureus to CHO epithelial cells and impact of SREC-I on the early phases of nasal
colonization in the cotton rat model. S. aureus adhesion to the cell line CHO expressing or not expressing SREC-I assayed in chamber slides
under shear stress (A) and under static conditions (B). Attachment of S. aureus wt, tagO, and tagO compl. evaluated microscopically by counting at
least 8 visible fields per well or chamber slide containing CHO cells without SREC-I or expressing full length SREC-I (A) or consecutive truncations of
the extracellular EGF-like domains (B). Means and SD of 4 independent experiments (static) or 3 independent experiments (flow) are shown. Statistical
analysis was performed by one-way ANOVA with Bonferroni’s multiple comparison test (A and B). Significant differences are indicated by one (P,
0.05), two (P,0.01), or three (P,0.001) asterisks (*). Nasal colonization was assayed in a cotton rat model (C). Bacterial numbers were determined 8 h
and 6 days after inoculation. 15 min prior to inoculation cotton rats were pretreated with 2 mg anti-SREC-I Fab2-fragment per nose. After 8 h and 6
days the noses were dissected and the bacterial CFU was evaluated on S. aureus selective highchrome agar. Statistical analysis was performed by
D’Agostino & Pearson omnibus normality test and a subsequent Kruskal-Wallis non-parametric ANOVA with Dunn’s Multiple Comparison Test (C).
Significant differences between groups are indicated by one (P,0.05), two (P,0.01), or three (P,0.001) asterisks (*).
doi:10.1371/journal.ppat.1004089.g006
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Recombinant DNA constructs
The GFP-tagged version of SREC-I was constructed by
amplifying the cDNA-clone of wt-SREC-I (IRATp970A0758D6,
RZPD: Deutsches Ressourcenzentrum fu¨r Genforschung GmbH)
with primers SREC-I sense 59-GACTAGATCT GACGA-
ACCCG AGCGCTGCCA CCG-39 and SREC-I antisense 59-
GACTGAATTC GTTCTGTTGG CCTGGAGATGG-39. The
resulting PCR fragments were cloned into pGEM-T easy TA-
vector system (Promega) and transferred by BglII/EcoRI digestion
and ligation into pEGFP-N1 (Clontech) resulting in GFP fused to
the carboxy-terminus of the expressed proteins. Truncated SREC-
I constructs were generated as follows: the amino-terminal domain
including the signal peptide was amplified with SREC-I sense
primer and SREC-SP-antisense (59-GACTCTCGAG TT-
GATCCTTC TGCCTCCAGC CTG-39). The C-terminal do-
main was sequentially truncated by PCR amplification using
SREC-I antisense primer together with the different sense primers
SREC-I-1EGF (59-GACTCTCGAG TCCGCTGCCC GGC-
CCAGTAC TG-39), SREC-I-2EGF (59-GACTCTCGAG TTC-
CCGTGCG CCTGCGGCCC CC-39), SREC-I-4EGF (59-
GACTCTCGAG CTGCCCTGCC CGGCAGGCAG CC-39)
or SREC-I-5EGF (59-GACTCTCGAG GGACCCCTGC CC-
CACTGGTA CC-39), respectively. The resulting PCR fragments
were cloned into pGEM-T easy TA-vector system. DNA
fragments containing either the signal peptide or truncated
versions of SREC-I were prepared by restriction with BglII/XhoI
or XhoI/EcoRI, respectively and were ligated into pEGFP-N1.
CHO cells were transfected with the resulting constructs as well as
with the empty vector pEGFP-N1. Stable cell clones were isolated
and maintained in Ham’s F12 medium (Gibco) supplemented with
10% FCS and 400 mg/ml G418.
Labeling of human SREC-I
Recombinant SREC-I Fc-chimera was purchased from R&D-
Systems. The molecule was reconstituted in PBS to a concentra-
tion of 100 mg/ml. EZ-link Sulfo-NHS-LC-Biotin (Pierce) was
used at a concentration of 50 mg/ml. The biotinylation reaction
was performed in a modified PBS-buffer (pH=8.5) for 30 min at
37uC. The reaction was stopped by extensively dialyzing against
PBS at a pH=7 in a Slide-A-Lyzer dialysis cassette (Pierce).
In addition SREC-I was labelled with FITC. Therefore 100 ml
of a FITC-solution (40 mM) in carbonate-buffer (pH=8.5) was
Figure 7. Model of SREC-I role in nasal colonization. SREC-I can be detected on growing nasal epithelial cells in the inner nasal cavity. S. aureus
WTA binds to SREC-I which mediates S. aureus adhesion to cells from the inner nasal cavity. This WTA/SREC-I interaction has a considerable impact on
nasal colonization. Therefore, we postulate a reservoir of S. aureus cells in the inner nasal cavity as a source for continuous colonization, which is at
least partially maintained by WTA dependent adhesion to epithelial cells.
doi:10.1371/journal.ppat.1004089.g007
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mixed with a SREC-I at a concentration of 100 mg/ml and
allowed to react for 1 h at 37uC. After that time period the
reaction was stopped by dialysis against PBS in a Slide-A-Lyzer
dialysis cassette (Pierce). We also labeled human recombinant
CD36 (R&D systems) with the same protocol.
Cell lines and primary cells
Primary human nasal epithelial cells (HNECs) were purchased
from Provitro (Berlin) and cultivated in airway epithelial growth
medium (Provitro). HNECs were used up to passage 6. Primary
cotton rat nasal epithelial cells (CRNECs) were isolated from
cotton rat noses. Cotton rats noses were digested ON in DMEM
with 10% FCS (Sigma), penicillin (100 U/ml), streptomycin
(100 mg/ml; Gibco,), and Collagenase Type VIII (Sigma). Then
tissue was transferred in DMEM culture medium containing 10%
FCS, penicillin (100 U/ml), and streptomycin (100 mg/ml). After a
significant amount of cells were detectable (72 h) cells were
detached with Trypsin (Sigma) and subcultured in DMEM
supplemented with 10% FCS (Sigma). Growth rate and morphol-
ogy was constantly monitored and cells were used up to passage 7.
Detection of SREC-I on HNEC and CRNEC cells by FACS-
analysis and immunofluorescence
Studies were performed as described before [45]. Cells were
detached by scraping in PBS supplemented with 1% FCS. SREC-I
was detected by using an anti human SREC mouse IgG2B
antibody (R&D). Cells were blocked with 10% FCS in PBS for
20 min at room temperature following incubation with the anti-
SREC antibody for 45 min at 4uC. Subsequently, cells were
washed twice and incubated for 45 min at 4uC with secondary
antibody (anti-mouse IgG –PE). Flow cytometric analysis was
performed using a BD FacsCalibur. As an isotype control we used
a mouse IgG2B (R&D systems).
For immunofluorescence detection of SREC-1 on HNECS and
CRNECs, cells were cultivated in Lab-TekII-Slides (Thermo) and
were fixed with 100% MeOH pa for 10 min at -20uC. 1% BSA (in
PBS) was added to the cells to block nonspecific staining. The cells
were incubated at room temperature for 1 h. Then the cells were
incubated with 10 mg/ml SREC-1 antibody (SREC-I/SR-F1 goat
IgG polyclonal antibody; R&D), 10 mg/ml isotype control
(Normal goat IgG; R&D systems), or blocking buffer (1% BSA
in PBS) for 1 h at room temperature and washed three times with
PBS. A donkey anti-Goat IgG-Cy5 (Milipore) was used as
secondary antibody (diluted 1:75). Nuclei were stained with
1 mg/ml DAPI (Applicam) and cytoskeleton was stained with
phalloidin-TRITC (SIGMA) for 5 min at room temperature. After
three washing steps with PBS the cells were mounted with Mowiol.
Microscopy was performed on a Zeiss LSM-710 NLO with Zen
2011 software.
Detection of SREC-I mRNA by RT-PCR
The SREC gene in CRNECs and HNECs was detected via RT-
PCR. RNA was isolated with the RNeasy Mini Kit (Qiagen). To
exclude DNA contamination, RNA was digested with 10 U of
RNase-free DNase I (Roche) and 40 U of RNasin ribonuclease
inhibitor (Promega) for 30 min at room temperature. DNase I
treatment was stopped using DNase Inactivation reagent (Am-
bion). RNA was transcribed using First Strand cDNA Synthesis
Kit (Fermantas) and 200 ng of random hexamer primers. PCR for
detection of the SREC gene this cDNA was amplified with
following primers. The sequence primers designed using the
mouse SREC-I sequence were SREC-m1 fwd 59AG-
CTGCCTTGCAACCCTGGA and SREC-m1 rev59AGG-
TGCCTGCAGGACAT GGC, respectively. The second primer
pair were SREC-m2 fwd 59TGGGACTAGAGCTGGTGTTCT
and SREC-m2 re59CAGATGGGGATGGTGCA TTCT. The
primers designed based on the human SREC-I sequence were
SREC-h1 fwd 59TGAAGCCGGGCCTCTGTCGA and SREC-
h1 rev59 CAGATGGGGATGGTG CATTCT as well as SREC-
h2 fwd 59CC TGCCAGAAAGACGAGGTG and SREC-h2
rev59CCAGGCTTGCATCGACAGAG.
Binding blots
Purified WTA was blotted on a nitrocellulose membrane by
pipetting. 5 ml of a WTA solution in 20 mM NaAcetat containing
200, 100, 50, 25 and 12.5 nmol Pi were spotted onto the
membrane. The blots were blocked in TBS containing 5% BSA.
After 3 washes with TBS-0.1% Tween20 the blots were incubated
with 500 mg/ml SREC-I Fc-chimera (R&D systems) in TBS at
room temperature for 30 min. After 1 wash with TBS-0.1%
Tween20 the blots were incubated with an anti-human IgG
antibody coupled with a 800 nm emitting infrared dye (LI-COR)
for 45 min. The blots were washed again once with TSB-0.1%
Tween20 and once with PBS and SREC/WTA interaction was
detected on a LI-COR Odyssey system.
Binding studies of soluble SREC-I to bacteria
Bacteria were cultured over night in MHB media and
subcultured until mid-logarithmic growth phase in IMDM. The
Bacteria were washed 3 times with PBS. The assay was performed
in a 300 ml scale and 1*108 bacteria were incubated with 50 mg/ml
FITC labeled SREC-I Fc-chimera (R&D systems) in PBS. After
30 min at 37uC and slow shaking, the bacteria were harvested by
centrifugation at 10000 rpm for 10 minutes. The bound fluores-
cence was calculated by subtracting the unbound fluorescence
from the total fluorescence of the FITC labeled SREC-I solution.
In some assays different MgCl2 concentrations or purified WTA
were added to test the charge dependency of the WTA/SREC-I
interaction. As a specificity control FITC labeled human CD36
(R&D systems) was used at 50 mg/ml.
Adherence of WTA-coated beads or whole bacteria to
CRNECs and HNECs
CRNECs were seeded in 24 well culture plates at 2.5–56104
cells/well in Dulbecco’s Modified Eagle Medium (DMEM; PAA
Laboratories) with 10% FCS, 100 U/ml penicillin, and 100 mg/
ml streptomycin, while HNECs (Provitro) were seeded at 56104
cells/well in airway epithelial growth medium (Provitro). The
Plates were incubated at 37uC under 5% CO2. Binding assays
where performed as described before [18]. When blocking
experiments were performed, 10 mg/ml anti-human SREC-I/
SR-F1 antibody (R&D systems) or 10 mg/ml isotype control
(normal goat IgG; R&D systems) were used in adhesion assays
with WTA coated latex beads (WTA passively adsorbed to amine
modified latex beads (Sigma) as described before [18]). The plates
were incubated for 30 min at 37uC. The antibody concentrations
were evaluated by dose dependency experiments (data not shown).
WTA-coated latex beads (wild type WTA and negatively charged
dltA WTA) and the control sample (only beads) were diluted in
RPMI 1640. The fluorescence of the WTA-coated beads and the
control sample was adjusted accordingly. Then, the samples were
used in adhesion assays on epithelial cells with bead/epithelial cell
ratios of 200:1, 20:1, 2:1 for dose dependency experiments. In
antibody blocking assays a ratio of 20:1 was used. The plates were
incubated for 1 h at 37uC. After a washing step with PBS the
relative fluorescence at 520 nm (emission) was quantified using a
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fluororeader (BMG Labtech). At least five assays were run in
triplicate. When bacteria where used, bacteria were prepared and
labeled with fluorescein isothiocyanate (FITC) as described before
[18]. For Cell numbers were adjusted using a Neubauer chamber.
5 independent assays were performed under static conditions.
When blocking experiments were performed, 10 mg/ml Fab2-
fragments of anti-human SREC-I/SR-F1 antibody (R&D systems)
or 10 mg/ml isotype control (normal goat IgG; R&D systems) were
used. Fab2-fragments were produced with a Pierce kit according to
the manufacturer’s description. When assays under flow conditions
were performed epithelial cells were seeded in chamber slides (m-
Slide VI0.4; Ibidi). For infection peristaltic pumps (Amersham)
were used with flow conditions mimicking 0.5 dynes, according to
the manufacturer’s instructions with a MOI of 20 (at 37uC under
5% CO2) for 30 min. 6 independent assays were performed under
flow conditions
Adhesion assays on CHO epithelial cells expressing full
length, truncated, or no SREC1-receptor under static and
flow conditions in chamber slides
Chinese hamster ovary (CHO) epithelial cells were seeded in
chamber slides (m-Slide VI0.4; Ibidi) at 16105 CHO cells/well and
in DMEM/F12-GlutaMaxTM-I medium (GIBCO) supplemented
with 10% fetal calf serum (FCS), 400 mg/ml geneticin (G418),
100 U/ml penicillin, and 100 mg/ml streptomycin and grown at
37uC under 5% CO2. Bacteria were prepared and labeled with
fluorescein isothiocyanate (FITC) as decribed before [18].
Adhesion to CHO cells containing the empty vector pEGFP-N1,
the vector with the full length SREC-I receptor, or the vector with
a truncated SREC-I receptor was assayed with FITC labeled
Staphylococcus aureus SA113 wild-type, S. aureus SA113 DtagO, or S.
aureus SA113 DtagO pRBtagO at a MOI of 10. After the infected
cells were incubated for 1 hour at 37uC under 5% CO2 the cells
were washed three times with phosphate-buffered saline (PBS) and
then fixed with 4% paraformaldehyde (PFA). Adherent bacteria/
0.1 mm2 were counted using a fluorescence microscope (Zeiss).
Three assays were run in duplicate.
Before assays under flow conditions were performed epithelial
cells were seeded in chamber slides (m-Slide VI0.4; Ibidi) at 66104
CHO cells/well and cultivated as described above. For infection
peristaltic pumps were used with flow conditions mimicking 0.5
dynes according to the manufacturer’s instructions with a MOI of
20 (at 37uC under 5% CO2) for 30 min. Adherent bacteria/100
epithelial cells were counted using a fluorescence microscope.
Three independent assays were performed.
Cotton rat model of nasal colonization
The cotton rat model was used as described earlier [18]. Cotton
rats were anesthetized and noses were preincubated for 15 min
with 2 mg of anti-human SREC-I Fab2-fragment (R&D) per nose.
Afterwards, the noses were instilled intranasally with 10 ml of
16109 colony forming units (CFU) of S. aureus (SA113). 8 hours
after bacterial instillation the animals were euthanized and noses
were removed surgically. The noses were vortexed in 1 ml of PBS
containing 0.5% Tween for 30 sec. Samples were plated on
appropriate agar plates and the bacterial CFU was determined. All
animals received drinking water with 2.5 mg/ml streptomycin
continuously, starting 3 days prior before beginning the experi-
ment to reduce the natural nasal flora.
Ethics statement
Animal experiments were performed in strict accordance with
the German regulations of the Society for Laboratory Animal
Science (GV-SOLAS) and the European Health Law of the
Federation of Laboratory Animal Science Associations (FELASA).
The protocol was approved by the Regierungspra¨sidium Tu¨bin-
gen (Permit Numbers: T1/10)).
Statistical analysis
Statistical analyses were performed with Graphpad Prism, using
appropriate statistical methods as indicated. P values#0.05 were
considered significant.
Supporting Information
Figure S1 WTA structure and biosynthesis. WTA is a cell
wall glycopolymer with a negatively charged ribitol-phosphate
backbone. The ribitol units are modified with positively charged
D-alanine esters (renders the polymer zwitterionic) and GlcNAc
residues in a or b-configuration. WTA biosynthesis occurs directly
at the cytoplasmic membrane, starting with the addition of
GlcNAc-P from UDP-GlcNAc to undecaprenol-phosphate by the
TagO enzyme. A tagO mutant lacks all WTA in the cell wall. After
the addition of ManNAc, the anchor structure is finished by
adding 3 glycerol-phosphate molecules. Then up to 40 ribitol-
phosphate molecules are polymerized step-wise until the WTA
molecule is finished and finally transported across the membrane
by TagGH. The mature polymer is linked to the C6 atom of
MurNAc in the the peptidoglycan and then modified with GlcNAc
and D-alanine. The addition of D-alaline esters are performed by
the gene products of the dlt-operon. A dltA mutants lacks the D-
alanylation and therefore exhibits negatively charged WTA.
(TIF)
Figure S2 Expression of SREC-I in HNECs and
CRNECs. Primary cotton rat nasal epithelial cells (CRNECs)
were isolated from nasal turbinates and monitored under culture
condition for morphological integrity by microscopy (A). Surface
exposure of SREC-I on HNECs and CRNECs was monitored by
FACS with the same anti-human SREC-I antibody and
appropriate isotype control. A PE labelled anti-mouse IgG
antibody was used as the secondary antibody. A representative
experiment is shown here (B) Expression of SREC-I in HNECs
and CRNECs was assayed with RT-PCR. Primer sets derived
from the human and murine SREC-I sequence were used (C). The
house keeping gene GAPDH was used as a control.
(TIF)
Figure S3 Surface presentation of SREC-I on CRNECs
and HNECs monitored by confocal microscopy. The
appropriate isotype control (A) and a mouse derived anti-human
SREC-I antibody (B) were used to stain SREC-I on the cellular
surface (upper panel CRNECs and lower panel HNECs
respectively). Cell nuclei were stained with DAPI. Bars represent
20 mm.
(TIF)
Figure S4 Direct binding of SREC-I to WTA. WTA was
spotted in increasing concentrations on a nitrocellulose membrane
(wild-type WTA squares, dltA WTA triangles) and interaction with
a SREC-I Fc-chimera (500 ng/ml) was measured. Bound SREC-I
Fc-chimera was detected with a secondary antibody coupled to an
800 nm emitting infrared dye on a LI-COR Odyssey infrared
imaging system. The mean and SD of 3 independent experiments
are shown.
(TIF)
Figure S5 Charge dependency and specificity of SREC-I
binding to WTA. Binding of SREC-I to whole bacterial cells,
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measured with a FITC-labeled SREC-I Fc-chimera (A). Wild-type
S. aureus and a dltA mutant with negatively charged WTA were
incubated with different concentrations of MgCl2 and 50 mg/ml
FITC-labeled SREC-I. In addition we added WTA purified from
wild-type S. aureus and dltA mutant. The bound fluorescence was
calculated by subtracting the unbound fluorescence from the total
fluorescence of the FITC-labeled SREC-I solution. The mean and
SD of 4 independent experiments are shown. Statistical analysis
was performed by one-way ANOVA with Bonferroni’s multiple
comparison test (A). Comparison of SREC-I WTA specific
binding with CD36 binding to whole bacterial cells. (B). Wild-
type S. aureus, tagO mutant (no WTA) and dltA mutant with
negatively charged WTA were incubated with 50 mg/ml of FITC-
labeled SREC-I or FITC labeled CD36. The bound fluorescence
was calculated by subtracting the unbound fluorescence from the
total fluorescence of the FITC-labeled SREC-I solution. The
mean and SD of 6 independent experiments are shown. Statistical
analysis was performed by one-way ANOVA with Bonferroni’s
multiple comparison test. Significant differences vs. wild-type
without MgCl2 are indicated by one (P,0.05), two (P,0.01), or
three (P,0.001) asterisks (*).
(TIF)
Figure S6 Confocal microscopy of S. aureus adhesion to
CRNECs. Green fluorescent S. aureus (FITC labeled) wild-type
(A) and tagO mutant (B) cells where allowed to adhere to cotton rat
nasal epithelial cells (CRNECs) under mild shear stress condition
(0.5 dynes) in ibidi-chamber slides. Cells were stained with DAPI
and phalloidin-TRITC. Bars represent 20 mm.
(TIF)
Figure S7 Amino acid sequence of SREC-I with putative
WTA binding site. Negatively charged amino acids are labeled
in red, positively charged amino acids in yellow (A). Model of
WTA-SREC-I interaction. Both the zwitterionic charge of the
WTA repeating units and the actual spacing of the charges are
required for SREC-I binding (B).
(TIF)
Figure S8 Charge dependency of WTA dependent adhe-
sion to nasal epithelial cells and SREC-I dependent
modulation of USA100 nasal colonization. Adhesion to
CRNECs, under shear stress conditions in ibidi chamber slide
assays, was monitored after preincubation of the bacterial
inoculums with different MgCl2 concentrations. The mean and
SD of 4 independent experiments are shown. Statistical analysis
was performed by one-way ANOVA with Bonferroni’s multiple
comparison test (A). Nasal colonization in the cotton rat model was
tested with USA100 (B). Bacterial numbers were determined 6
days after inoculation. 15 min prior to inoculation cotton rats were
pretreated with 2 mg anti-SREC-I Fab2-fragment per nose. After 6
days the noses were dissected and the bacterial CFU was evaluated
on S. aureus selective highchrome agar. Statistical analysis was
performed by one-way ANOVA with Bonferroni’s multiple
comparison test (B). Significant differences vs. wild-type without
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